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Abstract: Domoic acid is a marine biotoxin associated with harmful algal blooms and is the
causative agent of amnesic shell sh poisoning in marine animals and humans. It is also an
excitatory amino acid analog to glutamate and kainic acid which acts through glutamate re-
ceptors eliciting a very rapid and potent neurotoxic response. The hippocampus, among other
brain regions, has been identi ed as a speci c target site having high sensitivity to DOM
toxicity. Histopathology evidence indicates that in addition to neurons, the astrocytes were
also injured. Electron microscopy data reported in this study further supports the light mi-
croscopy  ndings. Furthermore, the effect of DOM was con rmed by culturing primary as-
trocytes from the hippocampus and the brain stem and subsequently exposing them to do-
moic acid. The RNA was extracted and used for biomarker analysis. The biomarker analysis
was done for the early response genes including c-fos, c-jun, c-myc, Hsp-72; speci c marker
for the astrocytes- GFAP and the glutamate receptors including GluR 2, NMDAR 1, NM-
DAR 2A and B. Although, the astrocyte-GFAP and c-fos were not affected, c-jun and GluR 2
were down-regulated. The microarray analysis revealed that the chemokines / cytokines, tyro-
sine kinases (Trk), and apoptotic genes were altered. The chemokines that were up-regulated
included - IL1-α, IL-1B, IL-6, the small inducible cytokine, interferon protein IP-10, CXC
chemokine LIX, and IGF binding proteins. The Bax, Bcl-2, Trk A and Trk B were all down-
regulated. Interestingly, only the hippocampal astrocytes were affected. Our  ndings suggestMar. Drugs 2008, 6(1) 26
that astrocytes may present a possible target for pharmacological interventions for the preven-
tion and treatment of amnesic shell sh poisoning and for other brain pathologies involving
excitotoxicity.
Keywords: Domoic acid, astrocytes, susceptibility, semi-quantitative analysis, electron mi-
croscopy
1. Introduction
Astrocytes account for 50% of the total cellular volume [1,2] and 90% of the number of brain cells.
These cells were traditionally thought to provide structural support for neuronal growth and differ-
entiation and to remove toxic metabolites from the extracellular environment [1,2,3]. The astrocytes
are also known to interact with the endothelial cells which form the blood brain barrier (BBB) and
regulate the  ow of chemicals in and out of the brain [1,2]. In addition to providing structural support,
astrocytes also participate in many other processes crucial for the brain through their abundance and
diverse ion channels, receptors, and transporters for neurotransmitters and neuromodulation [4-5].
Neurotoxicitycausedbyexcitatoryaminoacids(EAAs)suchasglutamatecontributestothepathol-
ogy of the central nervous system (CNS), including neurodegenerative disease, ischemia and trauma.
Glutamic acid and /or its structural analogues such as domoic (DOM) or kainic acid (KA) have been
proposed to mediate brain toxicity through their interaction with EAA receptors collectively known
as the glutamate receptors (GluRs). Sites often damaged are the hypothalamus by glutamate [6], the
hippocampal and neocortical pyramidal neurons by domoic acid [6], the cerebellar Purkinje neurons
by ibogaine [6-7] and the corpus striatum by 3-Nitropropionic Acid (3-NPA) and amphetamine [6].
The excitotoxic damage presents as neuronal loss and neuronal degeneration with characteristic cyto-
plasmic vacuolation and swollen dendrites. The regional distribution of the neuronal lesions re ects
that of the GluR distribution. Astrocytes with swollen perikarya and karyorrhexis have often been
observed in the vicinity of these lesions [8-9]. It has been suggested that astrocytes contribute to a
decline of neurologic function by either the accumulation and release of EAAs after ischemia and
oxidative stress or by formation of epileptogenic scars in response to CNS injury and metabolism of
protoxins to potent toxins. Recent evidence shows that in response to invasion by microorganisms,
both astrocytes and microglia mount an immune response by releasing cytokines [10-13]. Although it
is known that astrocytes and microglia are involved in the initiation, maintenance, and suppression of
immune responses, they have also been shown to propagate CNS damage [10-13]. Therefore, these
cells may also be involved in neurodegenerative disorders. Astrocyte activation (reactive gliosis) and
neuroin ammation are known to accompany neurotrauma, stroke, neurodegenerative disease or tu-
mors [14]. Since reactive gliosis represents a homotypic response to diverse insults of the CNS, it is
assumed that neuroin ammation is induced by a common set of signals. Cytokines, neurotrophins,
and neurohormones are potent biological response modi ers that exhibit a spectrum of cellular ac-
tions associated with a variety of neurotoxic exposures that induce neuroin ammation [10,15-17].
The signal transduction pathways and gene-activation events that link these chemical messengers to
glial activation are not yet fully characterized.Mar. Drugs 2008, 6(1) 27
Several mechanisms have been implicated as mediators for the effects of DOM [18,19]. These in-
clude the potential role played by astrocytes [20]. Acute toxicity studies, using single parenteral doses
of DOM, have shown light microscopy evidence of cell injury of the astrocytes in several brain re-
gions [21]. Here we provide additional morphologic evidence of the effects of DOM on astrocytes as
assessed by electron microscopy after subchronic oral administration of DOM in rats. We also further
explore the pathogenesis of the glial lesion induced by DOM and regional functionality using in vitro
astrocytes isolated from the hippocampus and the brain stem. Currently, limited information is avail-
able on the molecular events altered by DOM that may affect the function of astrocytes. Ultimately,
the characterization of the early cellular events subsequent to DOM intoxication will yield new in-
sights for the rational development of novel therapeutic interventions for the prevention and treatment
of amnesic shell sh poisoning and for other brain pathologies involving excitotoxicity.
2. Materials and Methods
2.1. Animal Experimentation
Sprague-Dawley rats (males and females), 34 to 38 days of age, were divided into three groups.
These animals were administered daily doses of 0.0, 0.1 or 5.0 mg/kg body weight of domoic acid
(Diagnostic Chemicals Ltd) or water (vehicle) by gavage using a  exible feeding tube. Animals were
dosed and monitored for 64 days [22]. At the end of the study, the rats were exsanguinated under
iso uorane anaesthesia, and perfused with either 10% neutral buffered formalin for light microscopy
or 2% glutaraldehyde:2% paraformaldehyde in Tyrode’s solution for electron microscopy [23].
2.2. Electron Microscopy
Samples were dehydrated in an increasing alcohol series, cleared with propylene oxide, in ltrated
and embedded in epoxy resin. Thin sections from the CA3 region of the hippocampus were mounted
on 200 mesh copper grids and stained with uranyl acetate and lead citrate. All observations were made
with a Zeiss 902 transmission electron microscope.
2.3. Primary Astrocyte Cell Culture
Astrocytes were cultured from newborn (day one) Sprague-Dawley rats as described earlier [23].
Brains were removed aseptically from the pups, minced and mechanically disrupted by vortexing
in Dulbecco’s modi ed Eagle’s medium (D-MEM D) containing penicillin (100 µ/mL) and strep-
tomycin (100 µg/mL). This suspension was passed through a sterile nylon mesh (pore size 70 µm)
followed by sieving through 10 µm mesh (Spectrum Labs Inc CA, USA) into D-MEM supplemented
with 20% (v/v) fetal bovine serum (FBS-Invitrogen Canada, Burlington. ON, Canada) containing
penicillin/streptomycin (100 µg/mL-Invitrogen Canada, Burlington. ON, Canada). Cultures for MTT
assays were placed in 96-well plates and seeded at 104 cells per well. For PCR and gene expres-
sion analysis, cells were cultured at 105/ml, in 75 cm2 cell culture  ask (Beckon-Dickinson Labware)
and incubated at 37 ◦C in 5% CO2 with 95% relative humidity. After 4 days of seeding, the culture
medium was replaced with D-MEM containing 10% FBS. Thereafter the medium was changed twice
a week. All subsequent experiments were performed on 21-day old cultures.Mar. Drugs 2008, 6(1) 28
2.4. Cell Viability
Astrocyte cultures (104 per well) in 96 well plates were incubated with 5 different concentrations
of domoic acid (0, 0.1, 1.0, 10, 100 and 1000 µM). The effect of DOM on the cell viability was
assessed by using MTT uptake assays as described by Mosmann [24]. MTT ( nal concentration, 0.25
mg/ml) was added to the medium and the cultures were incubated for 3 hrs at 37 ◦C in 5% CO2.
The medium was aspirated and the cells were washed twice with PBS and lysed with 100µl dimethyl
sulphoxide per well at room temperature. Absorbance was measured at 570 nm, with 630 nm as the
reference. The measurements were performed using a microplate reader (Dynatec MR 5000, Dynex
Technologies, Chantilly, VA, USA).
2.5. Neurotoxicology
For DOM toxicity, the astrocytes were plated at a density of 105 cells/mL in Primaria 75 mL  asks
(VWR International Ltd. Missasauga, ON, Canada) and exposed to domoic acid. Ten µM of DOM
was the optimal concentration for neurotoxicity, as determined in the cell viability assay and this was
mixed in the growth medium for 24 hr. For transcriptional analysis, the supernatant was removed,
and the cells were trypsinized and washed with PBS and stored at -80 ◦C until needed. Total RNA
was extracted using Trizol Reagent (Invitrogen Canada, Burlington, ON) and stored at -80 ◦C until
analyzed.
2.6. Microarray Analysis
The DNA microarray glass slides (RO1) were purchased from Mergen Ltd (San Leandro, CA). The
preparation of biotin-labelled cRNA probes was essentially as described by the manufacturer. Brie y,
the  rst and second strand cDNAs were synthesized using a cDNA synthesis kit from Roche Diag-
nostics Corporation (Indianapolis, IN, USA). The cDNA synthesis was performed according to the
manufacturer’s instructions using 10 µg of total RNA and the second strand cDNA was synthesized at
16 ◦C for 2 hrs. The residual RNA was digested by 15U RNase I at 37 ◦C for 30 min after ds-cDNA
synthesis. Proteinase K 3U was used to eliminate protein contamination. The double stranded cDNA
was cleaned by phenol, phenol/chloroform and chloroform sequentially.
To produce the biotin-labelled cRNA probes the ds-cDNA was used as the template. The ds-cDNA
was incubated with each of 3 µL rATP (75mM), rGTP (75 mM), rUTP (75 mM), rCTP (15 mM),
10x transcription buffer, T7 enzyme mix, and 4.5 µL biotin-14-CTP (10 mM) (Invitrogen Canada
Inc., Burlington. ON, Canada) at 37 ◦C for 4 hrs. The synthesized cRNA probes were puri ed using
Micro-Spin Columns.
For hybridization, the sheared probe was applied to the sealed hybridization chamber attached to
themicroarrayslideandallowedtohybridizeovernightat30 ◦C.Theslideswereremovedandwashed
under both low and high stringency conditions.
The slides were scanned with a Virtek ChipReader (Virtek Vision Corp., Waterloo, ON) and
analysed by the Array-Pro program (Media Cybernetics, Silver Spring, MD). The data was
transferred to Microsoft Excel for analysis. The genes that had a signal mean ratio which was
over 2- fold different in all the three pairs of slides (control and treatment) were further analysedMar. Drugs 2008, 6(1) 29
using semi-quantitative PCR. The PCR results were analysed using the AlphaEase program and
statistically analysed using the t-test in the Prism 4 software (GraphicPad, Prism 4, San Diego, CA,
USA).
2.7. Semi-Quantitative PCR
Total RNA was isolated from the primary culture astrocytes using Trizol Reagent (Invitrogen
Canada Inc., Burlington. ON, Canada) according to the manufacturer’s protocol. The cDNA se-
quences for the genes of interest were obtained from the National Center for Biotechnology Infor-
mation (NCBI) and primers were designed using Primer3 software. The synthesis of the primers was
carried done by Invitrogen Canada Inc. For RT-PCR analysis, 2 µg of total RNA was used for  rst
strand cDNA synthesis using the Superscript II reverse transcriptase (Invitrogen Canada Inc.) and
oligo(dT)12-18 primer. The cDNAs were then ampli ed by PCR using gene speci c primers and Taq
enzyme (Promega, Madison,WI). The PCR conditions were: denaturation at 94 ◦C for 1 min, anneal-
ing at 55 ◦C - 60 ◦C for 1 min, and extension at 68 ◦C for 1 min. Twenty eight cycles were used
for ampli cation followed by an extension at 68 ◦C for 10 min. The cDNA products were separated
in a 2% agarose gel [25] and were analysed by densiometric analysis using Chemimager software.
The internal house keeping gene was 18S (Ambion Inc.). Statistical analysis was done using t-test
(GraphPad, Prism 4, San Diego, CA, USA).
Figure 1. Micrographs from the CA 3 region of the hippocampus of untreated
controls and domoic acid treated rats (5.0 mg/kg/day). A). Control animal with well
preserved astrocyte-magni cation (Bar =1.1µm); B). Astrocyte from treated animal
showing minimal vacuolation (V) of the cytoplasm (Barr=1.1 µm); C). Control
animal with well preserved pyramidal neurons of the CA 3 region, (Bar=2.5µm);
D). Treated animal showing astrocyte cell necrosis (arrow) with disruption of the
cytoplasmic membrane and degenerating processes (Bar = 3.5µm).
   
Figure 1: 
Micrographs from the CA 3 region of the hippocampus of untreated controls and domoic acid treated  rats (5.0 
mg/kg/day). A). Control animal  with well preserved astrocyte-magnification (Bar =1.1μm); B). Astrocyte from 
treated animal showing minimal vacuolation (V) of the cytoplasm( Barr=1.1 μm); C). Control animal with  
well preserved  pyramidal neurons of the CA 3 region,(Bar=2.5μm); D). Treated animal showing astrocyte cell 
necrosis (arrow) with disruption of the cytoplasmic membrane and degenerating processes (Bar = 3.5μm).  
 
To further evaluate the effects of DOM on  astrocytes, primary astrocytes were cultured  from two different 
regions of the brain focusing on the brain stem and the hippocampus. The MTT assay  shows that the astrocytes 
from the  brain stem appeared to be more sensitive to higher (>10 uM) concentrations of DOM than those 
astrocytes from the hippocampus  (Figure 2A and 2B).   Hence,  10 μM of DOM was used for further 
experiments.  After 24 hrs of treatment with DOM,  the total RNA  was extracted  and used for transcriptional 
analysis. The initial analysis was done on  i). the early injury genes (EIGs) including  c-fos, c-jun, c-myc, Hsp-
72; ii). astrocyte specific markers-GFAP; iii).  the glutamate receptor subtypes - GluR 2, NMDAR 1, NMDAR 
2A, NMDAR 2B and  iv). the proliferating cell nuclear antigen (PCNA).    
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3. Results
Electron microscopy revealed morphological changes in the CA 3 region of the hippocampus of
animals treated for 64 days with 5.0 mg/kg/day of DOM as compared to the control and to animals
receiving 0.1 mg/kg/bw. Various degrees of degenerating astrocytes from minimal vacuolation of the
cytoplasm to necrosis were observed (Figure 1).
To further evaluate the effects of DOM on astrocytes, primary astrocytes were cultured from two
different regions of the brain focusing on the brain stem and the hippocampus. The MTT assay shows
that the astrocytes from the brain stem appeared to be more sensitive to higher (>10 uM) concentra-
tions of DOM than those astrocytes from the hippocampus (Figure 2). Hence, 10 µM of DOM was
used for further experiments. After 24 hrs of treatment with DOM, the total RNA was extracted and
used for transcriptional analysis. The initial analysis was done on i). the early injury genes (EIGs)
including c-fos, c-jun, c-myc, Hsp-72; ii). astrocyte speci c markers-GFAP; iii). the glutamate recep-
tor subtypes - GluR 2, NMDAR 1, NMDAR 2A, NMDAR 2B and iv). the proliferating cell nuclear
antigen (PCNA).
Figure 2. GraphshowingtheMTTassaysfortheastrocytesfromtheA-Hippocampus
(Hp) and B- Brain Stem (Bs). Five different concentrations of domoic acid (DOM)
were used. 10 µM of DOM was used for neurotoxicology experiments. A). The
MTT assays for the astrocytes from the hippocampus (Hp) and B. MTT assays for
the astrocytes cultured from the brain stem (Bs). O.D.- optical density.
 
Figure 2:  
Graph showing the MTT assays for the astrocytes from the A-Hippocampus  (Hp) and B- Brain Stem (Bs). 
Five different concentrations of domoic acid  (DOM) were used. 10 μM of  DOM was used for 
neurotoxicology experiments. A). The  MTT assays for the astrocytes  from the hippocampus (Hp) and B.  
MTT assays   for the astrocytes  cultured from the brain stem (Bs). O.D.- optical density. 
 
 
The c-jun was down-regulated whereas c-fos and Hsp-72 and the astrocyte specific marker (GFAP) were not 
affected.  The  glutamate receptor subtype GluR 2 was down-regulated over 2-fold, (Figure 3a), expression of  
NMDAR 1, 2A and 2B were not detected.  These observed changes were only in the astrocytes cultured from 
the hippocampus.  
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The c-jun was down-regulated whereas c-fos and Hsp-72 and the astrocyte speci c marker (GFAP)
were not affected. The glutamate receptor subtype GluR 2 was down-regulated over 2-fold, (Figure
3), expression of NMDAR 1, 2A and 2B were not detected. These observed changes were only in the
astrocytes cultured from the hippocampus.
Figure 3. (A) The semi-quantitative analysis of the PCR ampli cation of different
apoptotic markers: Bax-2, Bcl-2, Caspase-3, Bad and GluR 2 derived from RT-PCR
performed in triplicate. M: molecular biomarkers; A: control samples from the
hippocampus; B: astrocytes treated with 10 µM of DOM from the hippocampus; C:
control samples from the brain stem; and D: treated samples from the brain stem.
The gels were analysed using the Chemimager and the densities were measured
and statistically analysed using the t-test (GraphPad, Prism 4, USA). (B) Shows
a graph of the statistical analysis of the marker -Bax-2. C-control, T-astrocytes
treated with 10 µM of DOM. Hp- astrocytes isolated from the hippocampus region
and Bs- astrocytes isolated from the brain stem. The gels were analysed using the
Chemimager and the densities were measured and statistically analysed using the
t-test (GraphPad, Prism 4, USA).
 
 
 
Figure  3:  
A. The semi-quantitative analysis of the PCR amplification of different  apoptotic markers: Bax-2, Bcl-2, 
Caspase-3, Bad and GluR 2 derived from RT-PCR performed in triplicate.  M-molecular biomarkers; A  - 
control samples from the hippocampus;  B-astrocytes treated with 10 μM of DOM  from the 
hippocampus; C- control samples from the brain stem; and  D- treated samples from the brain stem.  The 
gels were analysed using the Chemimager and the densities were measured and statistically analysed 
using  the  t-test (GraphPad, Prism 4,USA). 
 
To get a global view of the transcriptional changes, three microarrays RO 1 DNA chips were used
for each analysis and the putative positive genes were con rmed using semi-quantitative PCR analy-Mar. Drugs 2008, 6(1) 32
sis. From the DNA chip analysis, only the chemokines/cytokines, tyrosine kinases and apoptotic
genes showed either up- or down-regulated gene expression. This analysis was supplemented with
other genes associated with these pathways absent from the DNA chips. The cytokines were all up-
regulated signi cantly as con rmed by the t-tests. These included IL-1α, IL-1β, IL-6, small inducible
cytokine, interferon protein IP-10, CXC chemokine LIX and IGF binding proteins (Figure 4). Addi-
tional genes which were examined including the transforming growth factor (TGF- α and B), tumor
necrosis factor (TNF-α), nerve growth factor (NGF), MIP-1 and IL-7. Of these, only the TNF-α and
TGF- β were affected (Table 1). The expression of the other genes were not affected by the exposure
to DOM. Other cytokines such as TGF-α , MIP-1, IL-7 and NGF were not induced after exposure to
DOM.
Table 1. Biomarkers analysis in the astrocytes after treatment with domoic acid.
Gene (Up-Regulated) Treatment/Control
TNF-α 2
IL-1α 2
IL-1B 2
IL-6 3
Small inducible cytokine 2
IP-10 2
CXC chemokine LIX 4
CD3 nc
MIP-1 nc
Down-Regulated Biomarkers
Trk-B 3
Trk-C 3
Bcl-2 2
Bax-2 3
Bad nc
Caspase-3 nc
TGF-β 3
Abbreviations: DOM: domoic acid; TNF: tumor
necrotic factor; IL: interleukins; IP 10: interferon-
inducible protein 10; TGF: tumour growth fac-
tor; Bax-2 and Bcl: two apoptosis-related genes;
Trk: tyrosine protein kinase; MIP: Macrophage
in ammatory protein; CD3: cluster of differ-
entiation; nc: no change. The treatment/control
represents the densiometric area of the treatment
divided by the densiometric area of the controls.Mar. Drugs 2008, 6(1) 33
Figure 4. (A) The semi-quantitative analysis of the PCR ampli cation of different
cytokinemarkers: TNF-α-(tumournecroticfactor), IP-10, IL-B,IL-α, andthehouse
keepinggene18S(3:7)derivedfromRT-PCRperformedintriplicates.M:molecular
biomarker; A: control samples from the hippocampus; B: astrocytes treated with
10 µM of DOM from hippocampus; C: control samples from the brain stem; and
D: treated samples from the brain stem. All the reactions were done in triplicate.
The gels were analysed using the Chemimager and the densities were measured
and statistically analysed using the t-test (GraphPad, Prism 4, USA). (B) Shows
a graph of the statistical analysis of the marker -IL-B. C- control, T- astrocytes
treated with 10 µM of DOM. Hp- astrocytes isolated from the hippocampus region
and Bs- astrocytes isolated from the brain stem. The gels were analysed using the
Chemimager and the densities were measured and statistically analysed using the
t-test (GraphPad, Prism 4, USA).
 
Figure 4: 
A. The  semi-quantitative analysis of the PCR amplification of different cytokine markers: TNF￿α-(tumour 
necrotic factor), IP-10,  IL-B, IL-α, and the house keeping gene 18S  (3:7) derived from RT-PCR 
performed in triplicates. M- molecular biomarker; A-control samples from the hippocampus;  B-
astrocytes treated with 10 μM of DOM  from hippocampus; C- control samples from the brain stem; and  
D- treated samples from the brain stem. All the reactions were done  in triplicate. The gels were 
analysed using the Chemimager and the densities were measured and statistically analysed using the  t-
test (GraphPad, Prism 4,USA). 
 
B.Shows a graph of the statistical analysis of the marker -IL-B. C- control, T- astrocytes treated with 10 μM of 
DOM. Hp- astrocytes isolated from the hippocampus region and Bs- astrocytes isolated from the brain 
stem. The gels were analysed using the Chemimager and the densities were measured and statistically 
analysed using  the  t-test (GraphPad, Prism 4,USA). 
 
Two speci c membrane receptors, Trk A and Trk B were down-regulated 3-fold, whereas, Trk C
was unaffected. In addition, the apoptotic genes- Bcl-2 and Bax were down-regulated 2 and 3 fold,
respectively, whereas, Bad and caspase-3 were not affected (Figure 3).
The oxidation markers- gamma-glutamylcysteine synthetase (GCS), glutathione-S-transferase
(GST), glutathione peroxidase (GPx), cyclooxygenase (COX-2), catalase and superoxide dismutase
(Zn and Mn dependent) were not affected.Mar. Drugs 2008, 6(1) 34
4. Discussion and Conclusions
Although several mechanisms have been implicated on the neurotoxic effect of DOM, the patho-
genesis of the glial lesion has received very little attention. This is despite the fact that regardless of
the cause of neuronal damage, reactive glial cells alwaysappear at and around the site of degener-
ation. Earlier studies have shown in addition to the neurons being affected [26], various degrees of
injury was observed in hippocampal astrocytes in animals that had received subchronic oral adminis-
tration of DOM. The present study demonstrated the ultra-structural morphologic changes are similar
to those observations reported by light microscopy in acute toxicity studies [21]. In support of the
in vivo studies, we also conducted in vitro studies using primary astrocytes from two different brain
regions- the hippocampus and the brain stem. These cells were exposed 24 hrs to DOM and a sys-
tematic analysis of the different pathways that have been implicated in neurotoxicity were examined.
Two different approaches were used-  rst, we examined the effects on the known genes that have
been reported to be affected by DOM exposure, which included the EIGs, astrocytes speci c marker
(GFAP), and the glutamate receptors (AMPA and the kainate subtypes). Secondly, we used microar-
ray technology to further elucidate the other pathways that might be involved. All the transcriptional
changes were observed only in the astrocytes from the hippocampus and not from the brain stem.
The GFAP biomarker of gliosis [27] was not changed in either of the in vivo [22,26] or the in vitro
studies conducted here. Of the EIG genes, only c-jun was decreased 2-fold, whereas the c-myc, c-fos
and the Hsp72 were not altered. Previous studies with neuron cultures have shown that c-fos reaches
a peak after 6 hrs of exposure to the stimulus and then declines, whereas c-jun is activated after 24
hrs of exposure and is followed by the induction of Hsp-72 [28,29]. The lack of altered expression
in GFAP and some of the EIGs, is simply due to the fact that the expression of these is transient and
measurements were done outside of the relevant time window [28,29].
DOM is structurally similar to the excitatory neurotransmitter glutamate and glutamate is known to
exert its affect by binding to and activating the ionotropic glutamate receptors (iGluRs) including the
subtypes NMDAR 1, GluR1, GluR 2, GluR 5, and GluR 6 in the neurons. Metabotropic receptors are
not involved in DOM toxicity [30]. In our study with astrocytes, only GluR 2 was increased 2-fold,
whereas no expression was detected for any of the NMDAR subtypes.
From the microarray analysis and con rmed by semi-quantitative analysis, the chemokines / cy-
tokines, tyrosine kinases (Trk), and apoptotic genes showed either up- or down-regulated gene ex-
pression. Several pro- and anti-in ammatory cytokines including TNF-α, IL-1α, IL-1B, IL-6, CXC
chemokine LIX, interferon protein IP-10, small inducible cytokine and IGF binding protein were up-
regulated 2x fold or higher. However, not all cytokines were altered since cytokines are regulated in
cascades. The IL-1B and TNF-α are known to initiate the early events which are pleiotrophic and
trigger general responses that are not speci c for the initiating stimulus or antigen [15] and these
were both up-regulated. The cytokines act by binding to speci c membrane receptors, which signal
the cell via second messengers, such as the tyrosine kinases (Trk), to alter its gene expression. The
Trk A and B were down-regulated 3-fold, whereas, Trk C was unaffected. The apoptotic genes, Bcl-2
and Bax were altered, whereas, BAD and caspase-3 were not affected. The R01 chip also had other
neural markers including the different ion channels such as potassium and sodium, γ-aminobutyric
acid, cholinergic and the serotonin receptors. None of these were changes.
The oxidation stress markers are known to occur at the site of in ammation, these can also con-Mar. Drugs 2008, 6(1) 35
tribute to damage. The activation of astrocytes can lead to the expression of inducible nitric acid oxide
synthase (INOS), superoxides and nitric oxide which are involved in the removal of free radicals. In
our study, the GSTα, GCS, catalase, superoxide dismutase (Zn and Mn dependent), inducible nitric
oxide (INOS) and COX-2 were not altered after 24 hrs exposure to DOM.
In our study the injury to the astrocytes was characterized by ultra-structural changes, in amma-
tory,immuno, growth factor, cytokines, and changes in the cell death genes. It has been shown that the
activation of the astrocytes is an important defence mechanism. Localized production of cytokines
and chemokines has been shown in many debilitating neurologic disorders such as multiple sclero-
sis, Alzheimer’s disease and AIDS [12,16,31]. As the brain ages, in ammatory events become less
well-regulated and hence environmental exposure can exacerbate the endogenous heightened CNS
in ammation [32]. Many chemokines are capable of directly regulating signal-transduction pathways
that are involved in a variety of cellular functions, which range from synaptic transmission to growth.
Clearly, the potential use of chemokines and their receptors as targets for therapeutic intervention in
CNS disease might now have to be considered in the context of the broader physiological functions
of these molecules. Therefore, an understanding of the different interactions between in ammatory
mediators leading to restricted local reaction is important in the development of novel therapeutics
for in ammatory CNS diseases [33,34,35]. This is facilitated further by the fact that astrocytes from
different regions show functional heterogeneity. Recently, Tomita et al. [36] showed that the spice cur-
cumin strongly inhibited the transcription of the cytokine MIP-2 which is mainly produced by the as-
trocytes. Ananth et al. [37] demonstrated that DOM-induced astrogliosis and neurodenegeration were
reduced after 5 days of melatonin administration. Hence, it might be possible to use anti-in ammatory
intervention to slow down the progression of many different forms of neurodegenerative diseases.
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